REFERENCES
1. Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer’s disease at
25 years. EMBO Mol Med. 2016, 8 : 595-608.
2. Jin M, Shepardson N, Yang T, Chen G, Walsh D, Selkoe DJ. Soluble
amyloid beta-protein dimers isolated from Alzheimer cortex directly
induce Tau hyperphosphorylation and neuritic degeneration. Proc
Natl Acad Sci U S A. 2011, 108 : 5819-5824.
3. Chiti F, Dobson CM. Protein misfolding, functional amyloid, and human
disease. Annu Rev Biochem. 2006, 75 : 333-66.
4. Cohen SIA, Cukalevski R, Michaels TCT, Šarić A, Törnquist M,
Vendruscolo M, Dobson CM, Buell AK, Knowles TPJ, Linse S. Distinct
thermodynamic signatures of oligomer generation in the aggregation of
the amyloid-β peptide. Nat Chem. 2018, 10 : 523-531.
5. Cawood, E.E.; Karamanos, T.K.; Wilson, A.J.; Radford, S.E.
Visualizing and Trapping Transient Oligomers in Amyloid Assembly
Pathways. Biophys Chem. 2021, 268 : 106505.
6. Nasica-Labouze J, Nguyen PH, Sterpone F, Berthoumieu O, Buchete NV,
Coté S, De Simone A, Doig AJ, Faller P, Garcia A., et al. Amyloid β
protein and Alzheimer’s disease: When computer simulations complement
experimental studies. Chem. Rev. 2015, 115 : 3518-3563.
7. Nguyen PH, Ramamoorthy A, Sahoo BR, Zheng J, Faller P, Straub JE,
Dominguez L, Shea JE, Dokholyan NV, De Simone A., et al. Amyloid
oligomers: A joint experimental/computational perspective on Alzheimer’s
disease, Parkinson’s disease, type II diabetes, and amyotrophic lateral
sclerosis. Chem Rev. 2021, 121 : 2545-2647.
8. Jeon J, Blake Wilson C, Yau WM, Thurber KR, Tycko R. Time-resolved
solid state NMR of biomolecular processes with millisecond time
resolution. J Magn Reson. 2022, 342 : 107285.
9. Strodel B. Amyloid aggregation simulations: challenges, advances and
perspectives. Curr Opin Struct Biol. 2021, 67 : 145-152.
10. Nguyen P, Derreumaux P. Understanding amyloid fibril nucleation and
Aβ oligomer/drug interactions from computer simulations. Acc Chem
Res. 2014, 47 : 603-611.
11. Barz B, Liao Q, Strodel B. Pathways of amyloid-β aggregation depend
on oligomer shape. J Am Chem Soc. 2018, 140 : 319-327.
12. Robustelli P, Piana S, Shaw DE. Developing a molecular dynamics
force field for both folded and disordered protein states. Proc
Natl Acad Sci U S A. 2018, 115 : E4758-E4766.
13. Nguyen TH, Nguyen PH, Ngo ST, Derreumaux P. Effect of cholesterol
molecules on Aβ1-42 wild-type and mutants trimers. Molecules.2022, 27 : 1395.
14. Chakravorty A, McCalpin SD, Sahoo BR, Ramamoorthy A, Brooks C.L.
3rd. Free gangliosides can alter amyloid-β aggregation. J Phys
Chem Lett. 2022, 13 : 9303-9308.
15. Boopathi S, Garduño-Juárez R. Calcium inhibits penetration of
Alzheimer’s Aβ1 -42monomers into the
membrane. Proteins. 2022, 90 : 2124-2143.
16. Ono K, Condron MM, Teplow DB. Structure-neurotoxicity relationships
of amyloid beta-protein oligomers. Proc Natl Acad Sci U S A.2009, 106 : 14745-14750.
17. Roche J, Shen Y, Lee JH, Ying J, Bax A. Monomeric Aβ1−40 and Aβ1−42
peptides in solution adopt very similar Ramachandran map distributions
that closely resemble random coil. Biochemistry 2016,55 : 762−775.
18. Chakraborty D, Straub JE, Thirumalai D. Differences in the free
energies between the excited states of Aβ40 and Aβ42 monomers encode
their aggregation propensities. Proc Natl Acad Sci U S A. 2020,117 : 19926-19937.
19. Granata D, Baftizadeh F, Habchi J, Galvagnion C, De Simone A,
Camilloni C, Laio A, Vendruscolo M. The inverted free energy landscape
of an intrinsically disordered peptide by simulations and experiments.Sci Rep. 2015, 5 : 15449.
20. Huang J, Rauscher S, Nawrocki G, Ran T, Feig M, de Groot BL,
Grubmüller H, MacKerell AD Jr. CHARMM36m: an improved force field for
folded and intrinsically disordered proteins. Nat Methods. 2017,14 : 71-73.
21. Lin YS, Bowman GR, Beauchamp KA, Pande VS. Investigating how peptide
length and a pathogenic mutation modify the structural ensemble of
amyloid beta monomer. Biophys J. 2012, 102: 315-324.
22. Ball KA, Phillips AH, Nerenberg PS, Fawzi NL, Wemmer DE, Head-Gordon
T. Homogeneous and heterogeneous tertiary structure ensembles of
amyloid-β peptides. Biochemistry. 2011, 50 : 7612-7628.
23. Bhattacharya S, Xu L, Thompson D. Long-range regulation of partially
folded amyloidogenic peptides. Sci Rep. 2020, 10 : 7597.
24. Zheng W, Tsai MY, Chen M, Wolynes PG. Exploring the aggregation free
energy landscape of the amyloid-β protein (1-40). Proc Natl Acad
Sci U S A. 2016, 113 : 11835-11840.
25. Bhowmik D, MacLaughlin CM, Chandrakesan M, Ramesh P, Venkatramani R,
Walker GC, Maiti S. pH changes the aggregation propensity of amyloid-β
without altering the monomer conformation. Phys Chem Chem Phys.2014, 16 : 885-889.
26. Vivekanandan S, Brender JR, Lee SY, Ramamoorthy A. A partially
folded structure of amyloid-beta(1-40) in an aqueous environment.Biochem Biophys Res Commun. 2011, 411 : 312-316.
27. Nguyen PH, Derreumaux P. Structures of the intrinsically disordered
Aβ, tau and α-synuclein proteins in aqueous solution from computer
simulations. Biophys Chem. 2020, 264 : 106421.
28. Zheng W, Tsai MY, Wolynes PG. Comparing the aggregation free energy
landscapes of amyloid beta(1-42) and amyloid beta(1-40). J Am Chem
Soc. 2017, 139 : 16666-16676.
29. Zhang Y, Zhu Y, Yue H, Zhao Q, Li H. Exploring the misfolding and
self-assembly mechanism of TTR (105-115) peptides by all-atom molecular
dynamics simulation. Front Mol Biosci. 2022, 9 : 982276.
30. Liu X, Ganguly P, Jin Y, Jhatro MJ, Shea JE, Buratto SK, Bowers MT.
Tachykinin neuropeptides and Amyloid β (25-35) assembly: friend or foe?J Am Chem Soc. 2022, 144 : 14614-14626.
31. Matthes D, Gapsys V, Daebel V, de Groot BL. Mapping the
conformational dynamics and pathways of spontaneous steric zipper
Peptide oligomerization. PLoS One. 2011, 6 : e19129.
32. He H, Liu Y, Sun Y, Ding F. Misfolding and self-assembly dynamics of
microtubule-binding repeats of the Alzheimer-related protein tau.J Chem Inf Model. 2021, 61 : 2916-2925.
33. Man VH, He X, Gao J, Wang J. Effects of all-atom molecular mechanics
force fields on amyloid peptide assembly: The case of PHF6 peptide of
tau protein. J Chem Theory Comput. 2021, 17 : 6458-6471.
34. Chiricotto, M.; Melchionna, S.; Derreumaux, P.; Sterpone, F.
Multiscale Aggregation of the Amyloid Aβ16-22 Peptide:
From Disordered Coagulation and Lateral Branching to Amorphous
Prefibrils. J Phys Chem Lett. 2019, 10 : 1594-1599.
35. Baftizadeh F, Biarnes X, Pietrucci F, Affinito F, Laio A.
Multidimensional view of amyloid fibril nucleation in atomistic detail.J Am Chem Soc. 2012, 134 : 3886-3894.
36. Nguyen PH, Sterpone F, Derreumaux P. Self-assembly of Amyloid-beta
(Aβ) peptides from solution to near in vivo conditions. J
Phys Chem B. 2022 doi: 10.1021/acs.jpcb.2c06375.
37. Klimov DK, Thirumalai D. Dissecting the assembly of Abeta16-22
amyloid peptides into antiparallel beta sheets. Structure. 2003,11 : 295-307
38. Santini S, Wei G, Mousseau N, Derreumaux P. Pathway complexity of
Alzheimer’s beta-amyloid Abeta16-22 peptide assembly. Structure.2004, 12 : 1245-1255.
39. Santini S, Mousseau N, Derreumaux P. In silico assembly of
Alzheimer’s Abeta16-22 peptide into beta-sheets. J Am Chem Soc.2004, 126 : 11509-11516.
40. Irbäck A, Wessén J. Thermodynamics of amyloid formation and the role
of intersheet interactions. J Chem Phys. 2015, 143 :
105104.
41. Li MS, Co NT, Reddy G, Hu C-K, Straub, JE, Thirumalai D. Factors
governing fibrillogenesis of polypeptide chains revealed by lattice
models. Phys. Rev. Lett. 2010, 105 : 218101.
42. Abeln S, Vendruscolo M, Dobson CM, Frenkel D. A Simple lattice model
that captures protein folding, aggregation and amyloid formation.PLoS One. 2014, 9 : e85185.
43. Bellesia G, Shea JE. Diversity of kinetic pathways in amyloid fibril
formation. J Chem Phys. 2009, 131 : 111102.
44. Šarić A, Chebaro YC, Knowles TP, Frenkel D. Crucial role of
nonspecific interactions in amyloid nucleation. Proc Natl Acad Sci
U S A. 2014, 111 : 17869-17874.
45. Chatterjee S, Nam Y, Salimi A, Lee JY. Monitoring early-stage
β-amyloid dimer aggregation by histidine site-specific two-dimensional
infrared spectroscopy in a simulation study. Phys Chem Chem Phys.2022, 24 : 18691-18702.
46. Man VH, Nguyen PH, Derreumaux P. High-resolution structures of the
amyloid-β 1-42 dimers from the comparison of four atomistic force
fields. J Phys Chem B. 2017, 121 : 5977-5987.
47. Itoh SG, Yagi-Utsumi M, Kato K, Okumura H. Key Residue for
Aggregation of Amyloid-β Peptides. ACS Chem Neurosci. 2022,13 : 3139-3151.
48. Sun Y, Kakinen A, Wan X, Moriarty N, Hunt CPJ, Li Y, Andrikopoulos
N, Nandakumar A, Davis TP, Parish CL, Song Y, Ke PC, Ding F. Spontaneous
formation of β-sheet nano-barrels during the early aggregation of
Alzheimer’s amyloid Beta. Nano Today. 2021, 38 : 101125.
49. Kłoniecki M, Jabłonowska A, Poznański J, Langridge J, Hughes C,
Campuzano I, Giles K, Dadlez M. Ion mobility separation coupled with MS
detects two structural states of Alzheimer’s disease Aβ1-40 peptide
oligomers. J Mol Biol. 2011, 407 : 110-124.
50. Nguyen HL, Linh HQ, Matteini P, La Penna G, Li, MS. Emergence of
barrel motif in amyloid-β trimer: A computational study. J Phys
Chem B. 2020, 124: 10617-10631.
51. Nguyen PH, Campanera JM, Ngo ST, Loquet A, Derreumaux P. Tetrameric
Aβ40 and Aβ42 β-barrel structures by extensive atomistic simulations.
II. In aqueous solution. J Phys Chem B. 2019, 123 :
6750-6756.
52. Lendel C, Bjerring M, Dubnovitsky A, Kelly RT, Filippov A, Antzutkin
ON, Nielsen NC, Härd T. A hexameric peptide barrel as building block of
amyloid-β protofibrils. Angew Chem Int Ed Engl. 2014,53 : 12756-12760.
53. Mirdita M, Schütze K, Moriwaki Y, Heo L, Ovchinnikov S, Steinegger
M. ColabFold: making protein folding accessible to all. Nat
Methods. 2022, 19 : 679-682.
54. Santuz H, Nguyen PH, Sterpone F, Derreumaux P. Small oligomers of
Aβ42 protein in the bulk solution with AlphaFold2. ACS Chem
Neurosci. 2022, 13 : 711-713.
55. Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O,
Tunyasuvunakool K, Bates R, Žídek A, Potapenko A., et al. Highly
accurate protein structure prediction with AlphaFold. Nature.2021, 596 : 583-589.
56. Hegedűs T, Geisler M, Lukács GL, Farkas B. Ins and outs of
AlphaFold2 transmembrane protein structure predictions. Cell Mol
Life Sci. 2022, 79 : 73.
57. Wong F, Krishnan A, Zheng EJ, Stärk H, Manson AL, Earl AM, Jaakkola
T, Collins JJ. Benchmarking AlphaFold-enabled molecular docking
predictions for antibiotic discovery. Mol Syst Biol. 2022,18 : e11081.
58. Martin J. When Alphafold2 predictions go wrong for protein-protein
complexes, is there something to be learnt? Q Rev Biophys. 2022,55 : e6.
59. Stein RA, Mchaourab HS. SPEACH_AF: Sampling protein ensembles and
conformational heterogeneity with Alphafold2. PLoS Comput Biol.2022, 18 : e1010483.
60. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H,
Shindyalov IN, Bourne PE. The Protein Data Bank. Nucleic Acids
Res. 2000, 28 : 235-242.
61. Kirkitadze MD, Condron MM, Teplow DB. Identification and
characterization of key kinetic intermediates in amyloid beta-protein
fibrillogenesis. J Mol Biol. 2001, 312: 1103-1119.
62. Fezoui Y, Teplow DB. Kinetic studies of amyloid beta-protein fibril
assembly. Differential effects of alpha-helix stabilization. J
Biol Chem. 2002, 277 : 36948-36954.
63. Lin Y, Sahoo BR, Ozawa D, Kinoshita M, Kang J, Lim MH, Okumura M,
Huh YH, Moon E, Jang JH. et al. Diverse structural conversion and
aggregation pathways of Alzheimer’s amyloid-β (1-40). ACS Nano.2019, 13 : 8766-8783.
64. Dammers C, Reiss K, Gremer L, Lecher J, Ziehm T, Stoldt M, Schwarten
M, Willbold D. Pyroglutamate-modified amyloid-β(3-42) shows α-helical
intermediates before amyloid formation. Biophys J. 2017,112 : 1621-1633.
65. Jayaraman M, Kodali R, Sahoo B, Thakur AK, Mayasundari A, Mishra R,
Peterson CB, Wetzel R. Slow amyloid nucleation via α-helix-rich
oligomeric intermediates in short polyglutamine-containing huntingtin
fragments. J Mol Biol. 2012, 415 : 881-899.
66. Mishra R, Jayaraman M, Roland BP, Landrum E, Fullam T, Kodali R,
Thakur AK, Arduini I, Wetzel R. Inhibiting the nucleation of amyloid
structure in a huntingtin fragment by targeting α-helix-rich oligomeric
intermediates. J Mol Biol. 2012, 415 : 900-917.
67. Sun Y, Kakinen A, Xing Y, Faridi P, Nandakumar A, Purcell AW, Davis
TP, Ke PC, Ding F. Amyloid self-assembly of hIAPP8-20 via the
accumulation of helical oligomers, α-Helix to β-sheet transition, and
formation of β-barrel intermediates. Small. 2019, 15 :
e1805166.
68. Misra P, Kodali R, Chemuru S, Kar K, Wetzel, R. Rapid α-oligomer
formation mediated by the Aβ C terminus initiates an amyloid assembly
pathway. Nat Commun. 2016, 7 : 12419.
69. Ruggeri FS, Longo G, Faggiano S, Lipiec E, Pastore A, Dietler G.
Infrared nanospectroscopy characterization of oligomeric and fibrillar
aggregates during amyloid formation. Nat Commun. 2015,6 : 7831.
70. Sun X, Lai L. Protein fibrils formed by rationally designed
α-helical peptides. Langmuir . 2020, 36 : 6126-6131.
71. Hauser CA, Deng R, Mishra A, Loo Y, Khoe U, Zhuang F, Cheong DW,
Accardo A, Sullivan MB et al. Natural tri- to hexapeptides self-assemble
in water to amyloid beta-type fiber aggregates by unexpected
alpha-helical intermediate structures. Proc Natl Acad Sci U S A.2011, 108 : 1361-1366.
72. Abedini A, Cao P, Raleigh DP. Detection of helical intermediates
during amyloid formation by intrinsically disordered polypeptides and
proteins. Methods Mol Biol. 2016, 1345 : 55-66.
73. Kim B, Do TD, Hayden EY, Teplow DB, Bowers MT, Shea JE. Aggregation
of chameleon peptides: Implications of α-helicity in fibril formation.J Phys Chem B. 2016, 120 : 5874-5883.
74. Jiang Y, Jiang X, Shi X, Yang F, Cao Y, Qin X, Hou Z, Xie M, Liu N,
Fang Q, Yin F, Han W, Li Z. α-Helical motif as inhibitors of toxic
amyloid-β oligomer generation via highly specific recognition of amyloid
surface. iScience. 2019, 17 : 87-100.
75. Kaffy J, Berardet C, Mathieu L, Legrand B, Taverna M, Halgand F, Van
Der Rest G, Maillard LT, Ongeri S. Helical γ-Peptide Foldamers as Dual
Inhibitors of Amyloid-β Peptide and Islet Amyloid Polypeptide
Oligomerization and Fibrillization. Chemistry. 2020, 26 :
14612-14622.
76. Kumar S, Hamilton AD. α-Helix mimetics as modulators of Aβ
self-assembly. J Am Chem Soc. 2017, 139 : 5744-5755.
77. Zheng X, Wu C, Liu D, Li H, Bitan G, Shea JE, Bowers MT. Mechanism
of C-Terminal Fragments of Amyloid β-Protein as Aβ Inhibitors: Do
C-Terminal Interactions Play a Key Role in Their Inhibitory Activity?J Phys Chem B. 2016, 120 : 1615-1623.
78. Ghosh S, Verma S. Carvedilol inhibits Aβ25-35fibrillation by intervening the early stage helical intermediate
formation: A biophysical investigation. Int J Biol Macromol.2021, 188 : 263-271.
79. Nguyen PH, Sterpone F, Campanera JM, Nasica-Labouze J, Derreumaux P.
Impact of the A2V mutation on the heterozygous and homozygous Aβ1-40
dimer structures from atomistic simulations. ACS Chem Neurosci.2016, 7 : 823-832.
80. Sonar K, Mancera RL. Characterization of the conformations of
amyloid beta 42 in solution that may mediate its initial hydrophobic
aggregation. J Phys Chem B. 2022, 126 : 7916-7933.
81. Tempra C, La Rosa C, Lolicato F. The role of alpha-helix on the
structure-targeting drug design of amyloidogenic proteins. Chem
Phys Lipids. 2021, 236 : 105061.
82. Fu Z, Van Nostrand WE, Smith SO. Anti-parallel β-hairpin structure
in soluble Aβ oligomers of Aβ40-dutch and Aβ40-iowa. Int J Mol
Sci. 2021, 22 : 1225.
83. Doig AJ, Del Castillo-Frias MP, Berthoumieu O, Tarus B,
Nasica-Labouze J, Sterpone F, Nguyen PH, Hooper NM, Faller P, Derreumaux
P. Why is research on amyloid-β failing to give new drugs for
Alzheimer’s disease? ACS Chem Neurosci. 2017, 8 :
1435-1437.
84. Doig AJ, Derreumaux P. Inhibition of protein aggregation and amyloid
formation by small molecules. Curr Opin Struct Biol. 2015,30 : 50-56.